Practice/Industry Group Overview
Build on Your Ideas.
Are you a biotech firm? A pharmaceutical or medical device company? A global life sciences leader? A start-up with a great idea under wraps? In our view, size doesn’t define you; mind set and actions do. You’re driven to make a difference and that drive makes you an ideal match for Mintz Levin. From the word “Go” to the words “Go public” and beyond, Mintz Levin lawyers provide business-building counsel based on a thorough understanding of your industry.
Companies like Biogen Idec turned to us at the birth of the industry in the 1970s. Today, ours is one of the deepest and largest life science practices in the country. This means that you can firmly rely on the legal resources you need at Mintz Levin. More importantly, you’ll gain an informed perspective on your business, your issues, and the best way to build and expand a sustainable enterprise around your ideas. Our combination of skills, experience, industry relationships, and like-minded thinking draws life science organizations like yours to Mintz Levin every day.
We represent biotechnology, medical device, and pharmaceutical companies, venture capital firms and investment banks, as well as research institutes and institutions of higher education located throughout the U.S., Europe, Asia, and the Middle East, in a broad range of transactional, regulatory, counseling, and intellectual property matters. Our Life Sciences service teams include attorneys, senior professionals, and PhDs with scientific or industry-specific experience and knowledge of finance, management and systems, clinical strategy, regulatory affairs, licensing, patents, corporate transactions, immigration, tax, manufacturing, accounting, product economics, and real estate.
From startup companies with a new idea to large public companies with products on the market, Mintz Levin attorneys will help:
- Complete mergers, acquisitions, and innovative financings.
- Defend intellectual property and product liability lawsuits.
- Navigate product launches.
- Negotiate strategic collaborations and alliances.
- Protect your intellectual property.
- Raise capital.
- Recruit and retain the best possible workforce while you stay focused on achieving your corporate goals.
Work Through Clinical and Other Trials.
Innovation requires a single-minded focus that can be challenging, especially when you have a company to run and a workforce to manage. But with research and development come challenges and opportunities that can require just as much focus and be equally rewarding. You need to create and protect intellectual property, raise capital, manage operations, build and expand facilities, recruit and retain talent, resolve disputes, enter into complex partnerships, and more. However, nurturing the health and well-being of your product development pipeline and its place in the market is your first priority.
To help you work through these challenges, clients turn to high-performing, interdisciplinary teams of Mintz Levin corporate, finance, IP licensing, real estate, litigation, and regulatory lawyers as well as professionals from our government affairs and PR affiliate, ML Strategies.
Do a Great Deal.
In your industry, capital and other transactions drive the engine, and R&D investments come with long-term and unpredictable returns. The more capital you have, the quicker you can move your products to market, so as your company expands you may be involved in many financings. You may complete venture rounds, mergers and acquisitions, enter into joint ventures and licensing agreements—and you may need to do multiple transactions at the same time. But each one is critical and needs to be executed efficiently while the opportunity is still in play. We do those deals every day at Mintz Levin. Which means we can help you find compatible partners, compare financing options, avoid unnecessary risks, and keep your wits about you to tackle the next deal—and the next.
With more than 400 Life Science clients, we provide comprehensive advice to both mature companies as well as to innovative pioneers. Mintz Levin offers you a view into the best practices and lessons learned by those on all sides of the rapidly-evolving Life Science landscape.
Sponsorships and Memberships
Mintz Levin‘s commitment to Life Sciences includes sponsorship of events and various memberships:
- AdvaMed - Member
- Astia NY Funding Series - Sponsor
- BayBio, Pantheon Awards - Event Sponsor
- BIO (Biotechnology Industry Organization) - Member, Sponsor BIO 2008
- BIOCOM - Sponsor, CEO Summit and Breakfast Series
- BSCP Evening of Hope - Sponsor
- California Health Institute
- Convergence Life Science Forum, Martha’s Vineyard, MA June 2008 - Sponsors, Fall 2007 and 2008 Life Science Dinners
- Enterprise Tuesday, London, UK - Sponsor
- Food and Drug Law Institute
- Helix Award, Sponsors ’07, ’08, ’09 — Founded by the Center for Biotechnology and Stony Brook University in 1996 and awarded annually in partnership with the Biotechnology Industry Organization (BIO), the award recognizes biotechnology companies that have distinguished themselves by setting a singular standard of corporate leadership as reflected in performance in the areas of scientific innovation and company growth.
- London Biotechnology Network 2008
- MassMedic - Member
- Medical Device Manufacturers Association - Member
- MIT Enterprise Forum - Member
- Regional Bioscience Association memberships including: MBC (MA), NYBA (NY), BIOCOM (San Diego), BayBIO (Northern CA), CHI (CA), MassMedic (MA), Council of State Bioscience Associations, Legal Hours at University of California at San Francisco, Astia Entrepreneur Program
- Wireless Life Sciences Association - Member
Pro Bono Services
In recent years, a member of the Firm’s Corporate practice has worked with the New York Biotechnology Association, Inc., a not-for-profit trade association dedicated to the development and growth of New York State based biotechnology related industries and institutions. The Mintz Levin attorney assisted in the presentation and preparation of educational programs and has provided advice to the Association on governance matters.